Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M223,009Revenue (TTM) $M50,877Net Margin (%)18.9Altman Z-Score3.8
Enterprise Value $M233,228EPS (TTM) $1.4Operating Margin %27.8Piotroski F-Score9
P/E(ttm)23.5Beneish M-Score-2.8Pre-tax Margin (%)25.7Higher ROA y-yY
Price/Book9.410-y EBITDA Growth Rate %1.0Quick Ratio0.9Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %1.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow22.4y-y EBITDA Growth Rate %7.8ROA % (ttm)12.7Higher Current Ratio y-yY
Dividend Yield %3.1PEG21.4ROE % (ttm)45.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,815ROIC % (ttm)27.1Gross Margin Increase y-yY

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

RHHBY is held by these investors:



RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about RHHBY:

    News about RHHBY:

    Articles On GuruFocus.com
    Roche Diagnostics recognizes Sentara Consolidated Laboratories as Roche Molecular Center of Excellen Apr 19 2017 
    Roche launches antibody test to aid in diagnosis of challenging prostate cancer cases Apr 12 2017 
    Roche launches new global Certified Provider Program for Target Enrichment in Genomic Sequencing Apr 11 2017 
    A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield Jan 24 2017 
    Blake Insomnia CEO Dreams of Improving Sleep Jan 04 2017 
    Roche's Leukemia Drug Approved for Next Step in Europe Dec 11 2016 
    Leith Wheeler Investment Funds 3rd Quarter Review Nov 01 2016 
    Roche, AbbVie: Venclyxto Receives Positive Opinion From Committee Oct 14 2016 
    Mairs and Power Buys Walt Disney, Exits Baxalta Sep 27 2016 
    Is Bristol-Myers Squibb Presenting an Opportunity? Sep 08 2016 

    More From Other Websites
    AstraZeneca Wallops Profit Views Despite Toppling Sales; Eyes Key Trial Apr 27 2017
    [$$] Roche Revenue Up 4% Apr 27 2017
    India watchdog orders antitrust probe into Roche cancer drug Apr 27 2017
    Roche Tops the Swiss Market After First Quarter Sales Beat Expectations Apr 27 2017
    New Data at AAN Reinforce Clinical Benefit of Genentech’s OCREVUS (Ocrelizumab) for Relapsing and... Apr 26 2017
    ETFs with exposure to Roche Holding AG : April 21, 2017 Apr 21 2017
    Roche Holding AG : RHHBY-US: Dividend Analysis : March 17th, 2017 (record date) : By the numbers :... Apr 21 2017
    Genentech to Present New Data at AAN Reinforcing Efficacy and Safety of Newly FDA Approved OCREVUS... Apr 19 2017
    After Johnson & Johnson Earnings, Buy These Pharma Stocks Apr 18 2017
    Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion Apr 18 2017
    Roche's Tecentriq wins FDA approval for treating advanced bladder cancer Apr 17 2017
    Roche's Hemophilia A Drug Positive in Second Phase III Study Apr 17 2017
    FDA Grants Genentech’s TECENTRIQ (Atezolizumab) Accelerated Approval as Initial Treatment for... Apr 17 2017
    Roche's Genentech says its drug for diabetes complication has been approved by FDA Apr 17 2017
    FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading... Apr 17 2017
    Roche's emicizumab haemophilia drug shows positive results with children Apr 17 2017
    Genentech Announces Positive Interim Results for Emicizumab in Phase III Study of Children with... Apr 17 2017
    Could Bristol's Drug Help Biogen Take AbbVie In Alzheimer's? Apr 13 2017
    Roche Launches Antibody Test to Diagnose Prostate Cancer Apr 13 2017
    Bristol-Myers to license two drugs to Biogen, Roche Apr 13 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)